According to our latest report entitled “US Stem Cell Market Analysis”, the US is one of the major stem cell markets in the world, and the country has been witnessing a significant level of positive development for the past few years. The US stem cell market was estimated to reach around US$ 830 Million in 2010, up from US$ 500 Million in 2009. The market has been well supported by factors, such as huge investment, strong demand, and rising disease incidences. Same factors will lead to generate US$ 3 Billion in the US stem cell market by 2013.
Our report has found that, all the key states in the US have been enacting measures that may reduce the controversies and strengthen the market related to stem cell technologies. The states, to augment the market potential, are providing ample support in the form of funding and grants. California, for instance, has funded various stem cell projects, of which 28% has been allocated to cancer, 23% to neurological diseases, and 13% to blood/immune disorders.
The report “US Stem Cell Market Analysis” provides an effective analysis and depiction of the US stem cell market, making use of reliable statistics and proper content flow. The report illustrates the current market trends and their impact on the future industry performance. It also investigates several clinical trials in the country that are making use of stem cells for the development of advanced treatments.
The report is an outcome of an extensive research and in-depth analysis of the US stem cell market that broadly specify all the key developments and important factors responsible for the industry performance. The forecasting in key areas of the report makes use of effective methods and techniques that further seek to present a realistic outlook. Last though not the least, the illustration of regulatory and competitive landscape completes the overall picture.
For more information visit: http://www.rncos.com/Report/IM191.htm |
